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osting by EAbstract Lipopolysaccharide (LPS) is a major cell wall molecule of Gram-negative bacteria
known to stimulate the synthesis and secretion of several toxic metabolites, such as reactive oxygen
species. In this study, the effect of pyrrolidine dithiocarbamate (PDTC), an antioxidant with nuclear
factor-jB inhibitor activity, was evaluated in LPS-induced oxidative stress and acute hepatic injury
in rats. Animals were pretreated for 3 consecutive days with PDTC (200 mg/kg/day, i.p.) or saline
and animals were then challenged with LPS (6 mg/kg, i.p.) or saline. Six hours after LPS injection,
animals were decapitated and blood and liver samples were collected to assess the chosen biochem-
ical parameters. Saline-pretreated animals challenged with LPS revealed extensive liver damage, as
evidenced by increases in serum levels of alanine aminotransferase (ALT), aspartate aminotransfer-
ase (AST) and gamma glutamyl transferase (c-GT). Also, LPS treatment resulted in signiﬁcant
increases in serum lactate dehydrogenase (LDH), tumor necrosis factor-alpha (TNF-a) and nitrite
levels. Furthermore, LPS challenge caused oxidative stress as indicated by an increase in hepatic
lipid peroxidation measured as thiobarbituric acid reactive substances (TBARS) and a decrease
in hepatic reduced glutathione concentration (GSH) as well as decreased activities of superoxide
dismutase (SOD) and catalase in hepatic tissues. The administration of PDTC prior to LPS chal-
lenge resulted in improved liver functions as evidenced by the decline in serum AST, ALT, c-GT
levels and reduction in serum LDH, TNF-a and nitrite levels. Moreover, PDTC reduced the chosen
lipid peroxidation marker, TBARS and increased GSH concentration, and SOD and catalaseoo.com, hhagar@gmail.ksu.
ity. All rights reserved. Peer-
d University.
lsevier
260 H.H. Hagaractivities in hepatic tissues. These results indicate that PDTC may be a useful pharmacological
agent in alleviating LPS-induced oxidative stress and acute hepatic injury.
ª 2009 King Saud University. All rights reserved.1. Introduction
Lipopolysaccharides (LPS) are glycolipids found in abundance
on the outer membrane of all Gram-negative bacteria and have
the ability to incite a vigorous inﬂammatory response (Su,
2002). LPS have been recognized for many years as a key risk
factor in the development of septic shock syndrome (Jaeschke,
2000; Jaeschke et al., 2002). Challenging of experimental ani-
mals with LPS causes a wide spectrum of pathophysiological
changes which parallel those observed in patients with
Gram-negative bacterial infections (Glaucer et al., 1991).
Gram-negative bacteria normally colonize the colon, so the
body has developed strong defensive mechanisms that tightly
regulate the entry and processing of LPS. The liver plays a cen-
tral role in this process (Su, 2002). The vast majority of LPS
that enters to the host in normal and pathological states does
so through the gastrointestinal tract (GIT). Strategically and
uniquely located at the gateway of the portal blood ﬂow drain-
ing the GIT, the liver is the ﬁnal barrier to prevent gastrointes-
tinal bacteria and bacterial products such as LPS, from
entering the systemic blood stream (Su, 2002). Systemic admin-
istration of LPS generally leads to its rapid accumulation in
hepatic Kupffer cells, which are the major cell type for the
detoxiﬁcation of the LPS endotoxin (Hewett and Roth,
1993). Hepatic Kupffer cells comprise approximately 70% of
the total macrophage population of the body. Under normal
conditions, Kupffer cells can efﬁciently clear non-pathogenic
amounts of circulating LPS (Hewett and Roth, 1993). After
challenging of experimental animals with LPS, it is taken up
rapidly by the liver within 5 min in rabbits (Mathison and
Ulevitch, 1979). In rats, hepatectomy (90%) resulted within
2 h in bacteriemia due to bacterial translocation, although
the phagocytic function of the lung and the spleen tissue cells
increased immediately (Wang et al., 1993). Therefore, the liver
appears to be a potent scavenger of circulating bacteria and
their products. Mild hepatic dysfunction might promote sys-
temic endotoxin spillover and the subsequent inﬂammatory
process, suggesting the importance of adequate liver function
to patient survival (Chaudry et al., 1986). Despite the ability
of the liver to detoxify LPS, marked morphological and bio-
chemical alterations can occur in hepatic tissues exposed to
vast amounts of LPS (Freudenberg and Galanos, 1992). Pa-
tients and experimental animals died from endotoxemia dis-
played alterations in Kupffer cells, formation of ﬁbrin
thrombi, neutrophil inﬁltration in liver sinusoids, and zonal
hepatic necrosis (Hewett and Roth, 1993; Freudenberg and
Galanos, 1992).
Endotoxemia occurs frequently in cases of liver failure and
is thought to play a role in the pathogenesis of liver disease
(Nakao et al., 1994). LPS interaction with the hepatic phago-
cytes namely, Kupffer cells is usually associated with their acti-
vation and subsequently the release of a plethora of mediators
(Decker, 1990) including reactive oxygen metabolites (ROM),
products of lipid metabolism (Jaeschke, 2000), and nitric oxide
(NO) Zhang et al., 2000 as well as proinﬂammatory mediators,such as tumor necrosis factor-a (TNF-a) Leist et al., 1995
which areresponsible for the recruitment and activation of neu-
trophils and other inﬂammatory cells known to augment tissue
injuries (Erzurum et al., 1992). All these mediators have raised
a considerable interest in recent years for their possible roles in
explaining the mechanisms of LPS-induced acute tissue
injuries.
Over the past few decades and, despite advances in antimi-
crobial therapy and critical care medicine, sepsis-related sys-
temic inﬂammatory syndrome and multiple organ
dysfunction continue to be the most common cause of morbid-
ity and mortality in intensive care units, reaching a mortality
rate of nearly 50%. Therefore, it is imperative to develop
new drugs or strategies that can arrest the many indolent
and deadly consequences of endotoxemia.
The dithiocarbamates are a class of antioxidants reported
to be potent inhibitors of nuclear factor kappa B (NF-jB)
both in vivo and in vitro (Shreck et al., 1992; Cuzzocrea
et al., 2002). The most potent member of this class is pyrroli-
dine dithiocarbamate (PDTC) that has been identiﬁed as a po-
tent antioxidant and has been used to counteract the toxic
effects of free radicals and to interfere with the generation of
proinﬂammatory cytokines (Liu and Malik, 1999). PDTC
has been advocated for the treatment of acquired immune deﬁ-
cient syndrome (AIDS) in HIV-infected patients and neurode-
generative diseases (Sunderman, 1991). Although PDTC has
been shown to have both anti-inﬂammatory and antioxidant
activities (Shreck et al., 1992; Tsuchihashi et al., 2003) yet its
effects on oxidative stress induced by endotoxin intoxication
in the liver has not been fully elucidated. The current investiga-
tion aimed to study the effect of PDTC on oxidative stress and
acute hepatic injury induced by LPS administration in rats and
to characterize the possible mechanisms by which PDTC might
attenuate endotoxin-induced hepatic injury. In the present
study, hepatic dysfunction was assessed by measuring serum
levels of alanine aminotransferase (ALT, a speciﬁc marker
for hepatic parenchymal injury), aspartate aminotransferase
(AST, a non-speciﬁc marker for hepatic parenchymal injury),
gamma glutamyl transferase (c-GT, a marker for cholestasis)
and lactate dehydrogenase (LDH, an indicator of cytotoxic-
ity). The present study also investigated the effects of PDTC
on serum nitrite and tumor necrosis factor-a (TNF-a) levels
as well as oxidative stress markers in an effort to gain better
insight into the mechanisms of the protective effects of PDTC
in LPS-challenged rats.2. Materials and methods
2.1. Chemicals
Lipopolysaccharide [(Escherichia coli LPS 0127:B8) lyophilized
powder chromatographically puriﬁed by gel ﬁltration (protein
content <1%)], pyrrolidine dithiocarbamate, N-(1-naphthyl)
ethylenediamine dihydrochloride, sulfanilamide, 5,5-dithi-2-
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oxypropane in addition to all other chemicals were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). Kits used
to measure ALT, AST, c-GT and LDH were purchased from
Spinreact Inc., (France). Superoxide dismutase activity was
measured using Ransod kit (Randox Laboratories Ltd., An-
trim, UK). TNF-a kit was obtained from R&D system (Minne-
apolis, MN, USA).
2.2. Animals
Adult male Sprague–Dawley rats weighing 200–220 g were ob-
tained from the animal house, College of Pharmacy, King
Saud University. All animals were housed in stainless-steel
cages with free access to pelleted Purina laboratory chow
and tap water. The rats were kept at room temperature (22–
24 C) and 55 ± 5% relative humidity with a regular 12-h light
and 12-h dark cycle. Animals used in this study were treated
and cared for in accordance with the strict guiding principles
of the National Institution of Health for experimental care
and use of animals. The experimental design and procedures
were approved by the Institutional Ethical Committee for Ani-
mal Care and Use at the King Saud University, Riyadh, King-
dom of Saudi Arabia.
2.3. Experimental design
Animals were randomly allocated into four groups, 8 animals
each. Group I (control group) treated with an equivalent vol-
ume of saline alone. Group II (PDTC-treated group) received
PDTC (200 mg/kg/day, i.p.) for 3 consecutive days. Group III
(LPS-treated group) challenged with a single dose of LPS
(6 mg/kg, i.p.) Collin et al., 2004. Group IV (PDTC and
LPS-treated group) pretreated with 3 doses of PDTC
(200 mg/kg/day, i.p.) 48, 24 and 1 h before being challenged
with LPS (6 mg/kg, i.p.). PDTC and LPS were dissolved in sal-
ine shortly before use. The dose and duration of PDTC treat-
ment was chosen based on previous studies (El Eter et al.,
2005; Hagar et al., 2007) as well as preliminary experiments.
2.4. Collection of samples
Six hours after LPS injection, animals were decapitated; blood
samples were collected and sera were separated by centrifuga-
tion at 3000g for 10 min and then stored at 70 C. Collected
samples were used within 48 h for the determination of the
chosen biochemical parameters. Livers were isolated and trea-
ted as described below.
2.5. Hepatic tissue preparation
Livers were excised from animals immediately after decapita-
tion and rinsed with ice-cold saline to remove excess blood.
All subsequent steps were carried out at 4 C. Following rins-
ing, livers were ﬁnely minced. Approximately 1 g of hepatic tis-
sues was homogenized with a Brinkmann Polytron in a
sufﬁcient volume of ice-cold 50 mM potassium phosphate buf-
fer, (pH 7) to produce a 10% (w/v) homogenate which was
centrifuged at 3000g for 10 min. The supernatants were frozen
in liquid nitrogen and kept at 80 C for the subsequent
assessment of lipid peroxidation marker and antioxidant
enzymes.2.6. Measurement of serum liver function enzymes
Hepatic dysfunction was assessed by measuring the rise in ser-
um levels of ALT, AST and c-GT using commercially avail-
able kits. The results were expressed as U/L.
2.7. Measurement of serum LDH
Serum lactate dehydrogenase (LDH) level was assessed using
commercially available kit according to the manufacturer’s
direction. The results were expressed as U/L.
2.8. Measurement of serum nitrite
Serum nitrite level was measured following the Griess reaction
(Green et al., 1981). Serum samples were diluted and deprote-
inized by adding 1/20th volume of 30% zinc sulphate solution.
After centrifugation of the samples at 3000g for 15 min 100 ll
of supernatants were incubated with 100 ll of Griess reagent
(0.1% N-(1-naphthyl) ethylenediamine dihydrochloride; 1%
sulfanilamide in 5% phosphoric acid) at room temperature
for 20 min. The absorbance was measured spectrophotometri-
cally (Lambada 5, Perkin–Elmer, Promona, USA) at 550 nm.
The concentration of nitrite was calculated using sodium ni-
trite as a standard and expressed as lmol/L.
2.9. Estimation of serum TNF-a
Serum TNF-a level was measured by an enzyme-linked immu-
nosorbent assay (ELISA) kit (rat TNF-a ELISA) (sensitivity:
<10 pg ml1), according to the instructions of the manufac-
turer. Brieﬂy, after thawing 50 ll of serum samples were di-
luted 1:2 with the provided diluents to stay within the linear
range of the assay. The samples were then incubated in micro-
wells coated with mouse anti-rat TNF-a for 2 h at room tem-
perature. After repeating the aspiration and washing for four
times, 100 ll of the biotinylated goat anti-rat TNF-a was
added to each well and incubated for 2 h. After washing,
100 ll of streptavidin conjugated to horseradish peroxidase
was added to the wells and incubated for 20 min. Following
a wash to remove unbound antibody-enzyme reagent, 100 ll
of substrate solution was added. The color intensity of the
enzymatic indicator reaction was measured photometrically
at 450 nm in an ELISA plate reader (ELx 808 Ultra Micro-
plate Reader BIO-TEK Instruments Inc., USA) and results
were expressed as pg/ml.
2.10. Determination of hepatic lipid peroxidation
Lipid peroxidation, as an indicator of oxidative stress, was esti-
mated by measuring thiobarbituric acid reactive substance
(TBARS) that sometimes referred to as malondialdehyde
(MDA) in hepatic homogenates as previously described (Buege
and Aust, 1978). Brieﬂy, 1 ml of 10% liver homogenate was re-
acted with 2 ml of fresh solution of thiobarbituric acid (TBA)
reagent containing 0.375% TBA, 15% tichloroacetic acid
(TCA), and 0.25 N HCl. The mixture was heated at 95 C for
15 min, and then cooled to room temperature using tap water
and centrifuged at 3000g for 10 min. Absorbance of the
pink supernatant was determined spectrophotometrically at
532 nm. The amount of MDA was expressed as nmol/g wet he-
patic tissue using 1,1,3,3-tetramethoxypropane as a standard.
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Hepatic superoxide dismutase (SOD) activity was measured
according to the method described by Sun et al. (1988). The
principle of the method is based on the inhibition of nitroblue
tetrazolium (NBT) reduction by the xanthine–xanthine oxidase
system as a superoxide generator. One unit of SOD was de-
ﬁned as the enzyme amount causing 50% inhibition in the
NBT reduction rate. The absorbance was measured at
505 nm and SOD activity was expressed as U/mg wet hepatic
tissue.
2.12. Measurement of hepatic catalase
Hepatic catalase activity was determined by a colorimetric
method based on the decomposition of hydrogen peroxide
(H2O2) (at 20 C, pH 7.0), by catalase, which can be followed
directly by the decrease in the absorbance at 240 nm (Higgins
and Bachne, 1978). Sample (50 ll) was placed in 900 ll phos-
phate buffer (50 mM, pH 7.0) and subsequently the reaction
was started by the addition of 50 ll H2O2 (30 mM, in phos-
phate buffer) to the sample cuvette. The decrease in absor-
bance at 240 nm was followed for every min for about 2 min.
The speciﬁc activity of catalase was expressed as the number
of lmol H2O2 decomposed/min/mg wet hepatic tissue.
2.13. Determination of hepatic reduced glutathione
Reduced glutathione (GSH) concentration in hepatic homoge-
nate was determined by the method of Ellman (1959). Proteins
in the samples of 0.5 ml liver homogenate (10%) were precip-
itated by the addition of 0.5 ml of 15% TCA solution. After
40 min, the protein precipitate was separated from the remain-
ing solution by centrifugation at 1000g at 4 C for 5 min.
Supernatant (200 ll) was combined with 1.7 ml of phosphate
buffer (50 mM, pH 8.0) and 100 ll of Ellman’s reagent (5,5-
dithio-2-nitrobenzoic acid) in phosphate buffer and the absor-
bance was measured spectrophotometrically at 412 nm. The
GSH concentration was determined using a standard curve
constructed with different concentrations of an authentic sam-
ple. The results were expressed as nmol/g wet tissue weight.
2.14. Statistical analysis
The degree in variability of results was expressed as means
± SEM. Data were evaluated by one-way analysis of variance
(ANOVA) followed by Tukey–Kramer multiple comparisons
test. The level of signiﬁcance was accepted at P< 0.05.Figure 1 Effects of prior administration of pyrrolidine
dithiocarbamate (200 mg/kg/day, i.p.) for 3 consecutive days
on serum liver enzyme levels, (A) alanine aminotransferase; (B)
aspartate aminotransferase and (C) c-glutamyl transferase in
lipopolysaccharide (6 mg/kg, i.p.)-induced hepatic injury in rats.
Values are expressed as mean ± SEM, n= 8. *P< 0.001
compared with control group, #P< 0.01 compared with LPS
group.3. Results
3.1. Effects of PDTC on LPS-induced liver injury
Injection of LPS in a dose level of 6 mg/kg, i.p. resulted in a
considerable hepatic injury as assessed by elevations of serum
ALT and AST and c-GT levels (Fig. 1A–C). These markers
were substantially elevated by about sevenfold, ninefold and
threefold, respectively, when compared with that of saline-
treated animals. Three consecutive days prior administration
of PDTC (200 mg/kg/day, i.p.) signiﬁcantly decreased the
LPS-induced elevations in serum ALT, AST and c-GT levels
Figure 2 Effect of prior administration of pyrrolidine dithiocar-
bamate (200 mg/kg/day, i.p.) for 3 consecutive days on serum
lactate dehydrogenase activity in lipopoly-saccharide (6 mg/kg,
i.p.)-induced hepatic injury in rats. Values are expressed as
mean ± SEM, n= 8. *P< 0.001 compared with control group,
#P< 0.001 compared with LPS group.
Figure 3 Effect of prior administration of pyrrolidine dithiocar-
bamate (200 mg/kg/day, i.p.) for 3 consecutive days on serum
tumor necrosis factor-a level in lipopoly-saccharide (6 mg/kg,
i.p.)-induced hepatic injury in rats. Values are expressed as
mean ± SEM, n= 8. *P< 0.01 compared with control group,
#P< 0.05 compared with LPS group.
Figure 4 Effect of prior administration of pyrrolidine dithiocar-
bamate (200 mg/kg/day, i.p.) for 3 consecutive days on serum
nitrite level in lipopolysaccharide (6 mg/kg, i.p.)-induced hepatic
injury in rats. Values are expressed as mean ± SEM, n= 8.
*P< 0.001 compared with control group, #P< 0.001 compared
with LPS group.
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(Fig. 1A–C).
3.2. Effect of PDTC on serum LDH level in LPS-treated rats
Serum LDH level was signiﬁcantly greater after LPS adminis-
tration than saline-treated control group by about 202.2%,
suggesting some sort of membrane instability induced by endo-
toxin (Fig. 2). Treatment of rats with PDTC (200 mg/kg/day,
i.p.) for 3 consecutive days signiﬁcantly decreased the elevation
in serum LDH level by about 31.3.1% as compared to animals
treated with LPS alone (Fig. 2).
3.3. Effect of PDTC on serum TNF-a level in LPS-treated rats
Injection of LPS at a dose level of 6 mg/kg, i.p. resulted in sig-
niﬁcant increase in serum TNF-a level compared to saline-
treated control animals (Fig. 3). Prior administration of PDTC
(200 mg/kg/day, i.p.) for 3 consecutive days signiﬁcantly re-
duced the elevation in serum TNF-a level by about 42.1% as
compared to LPS-treated group (Fig. 3).
3.4. Effect of PDTC on serum nitrite level in LPS-treated rats
Induction of endotoxemia by LPS resulted in a signiﬁcant ele-
vation in serum nitrite level by about 11.1-fold compared to
the control group value (Fig. 4). Treatment with PDTC
(200 mg/kg/day, i.p.) for 3 consecutive days prior to induction
of endotoxemia signiﬁcantly reduced the serum nitrite level to
23.44% in comparison with the corresponding value in LPS-
treated rats alone (Fig. 4).
3.5. Effect of PDTC on hepatic MDA concentration in LPS-
treated rat
As illustrated in Table 1, rats injected with a single dose of LPS
(6 mg/kg, i.p.) caused an increase in the formation of lipid per-
oxides, measured as MDA in hepatic tissues, by about 288%.
Pre-treatments with PDTC (200 mg/kg/day, i.p.) for 3 consec-utive days signiﬁcantly attenuated LPS-evoked increase in
MDA concentration reaching to a value of 52.7% compared
to that in group treated with LPS alone (Table 1).
3.6. Effect of PDTC on hepatic GSH concentration in
LPS-treated rats
The effect of PDTC on GSH concentration in LPS-treated
animals is presented in Table 1. Results showed that LPS de-
creased GSH content by about 40.8% in the liver as compared
to saline-treated control rats. Prior treatment with PDTC
(200 mg/kg/day, i.p.) for 3 consecutive days was able to signif-
icantly increase the hepatic concentration of GSH up to
Table 1 Effects of prior administration of pyrrolidine dithiocarbamate (200 mg/kg/day, i.p.) for 3 consecutive days on hepatic
thiobarbituric acid reactive substances and reduced glutathione contents as well as superoxide dismutase and catalase activities in
lipopolysaccharide (6 mg/kg, i.p.)-induced liver injury in rats.
TBARS GSH SOD Catalase
(nmol/g) (nmol/g) (U/mg) (lmol/min/mg)
Control 25.4 ± 2.11 3125 ± 113 8.12 ± 0.27 4.75 ± 0.12
PDTC 27.23 ± 3.10 3043 ± 110 8.46 ± 0.19 4.86 ± 0.17
LPS 72.43 ± 5.22* 1850 ± 116* 5.18 ± 0.19* 2.29 ± 0.13*
LPS + PDTC 38.31 ± 4.13# 3110 ± 115# 7.54 ± 0.32# 3.91 ± 0.11#
Values are expressed as means ± SEM, n= 8.
* Signiﬁcant difference from control group (P< 0.001).
# Signiﬁcant difference from LPS-treated group (P< 0.001).
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ted group.
3.7. Effect of PDTC on hepatic SOD activity in LPS-treated
rats
Hepatic SOD activity was signiﬁcantly decreased in the samples
of LPS-treated rats by about 36.2% in comparison with the
control group (Table 1). Administration of PDTC (200 mg/
kg/day, i.p.) for 3 consecutive days before LPS injection pro-
tected from LPS-induced decline in hepatic SOD activity reach-
ing a value of 145.5% as compared to the corresponding value
of LPS-treated group.
3.8. Effect of PDTC on hepatic catalase activity in LPS-treated
rats
Hepatic catalase activity was signiﬁcantly lowered in the LPS-
treated group reaching about 48.2% when compared with the
value of saline-treated control group (Table 1). However, cat-
alase activity was increased in LPS group pretreated with
PDTC (200 mg /kg/day, i.p.) for 3 consecutive days up to
170.7% compared with the value of LPS-treated group alone.
3.9. Effect of PDTC on treatment on the measured biochemical
parameters
No signiﬁcant changes were observed in the measured param-
eters in group treated with PDTC alone.
4. Discussion
Hepatic dysfunction after sepsis is a frequent event that is
characterized by loss of synthetic function, hepatocellular
necrosis, and release of inﬂammatory mediators such as
TNF-a, interleukin-1b, interleukin-6, and NO (Zhang et al.,
2000). The present study demonstrates that LPS-induced endo-
toxemia resulted in impairment in liver functions that was
manifested by increased serum ALT, AST and c-GT levels.
Moreover, serum levels of LDH, nitrite and TNF-a were ele-
vated by LPS administration. Endotoxemia also induced oxi-
dative stress that was revealed by increased hepatic TBARS,
a marker of lipid peroxidation, decline in hepatic GSH concen-
tration and SOD and catalase activities. Prior administration
with PDTC, an antioxidant with NF-jB inhibitor activity alle-
viated LPS-induced impairment in liver functions and reduced
serum LDH, nitrite and TNF-a levels Moreover, PDTC wasable to provide protection against LPS-induced oxidative
stress.
Proinﬂammatory cytokines play an important role as
mediators in the pathophysiology of various diseases includ-
ing endotoxin-induced shock (De la Fuente and Victor,
2001). In the present study, LPS-induced an increase in serum
TNF-a level and this was dramatically attenuated by PDTC
treatment. TNF-a is a potent inﬂammatory cytokine pro-
duced by the monocyte-macrophage lineage, including hepa-
tic Kupffer cells (Enomoto et al., 2003). It has been
reported that with LPS model, TNF-a is the central proximal
mediator, which controls all subsequent events (Jaeschke,
2000; Enomoto et al., 2003). TNF-a can induce the produc-
tion of other cytokines, adhesion molecules, arachidonic acid
metabolites. Liver is the major source for the increase in ser-
um TNF-a in endotoxin-induced shock in animals (Kumins
et al., 1996). Inhibition of TNF-a synthesis or activity atten-
uates liver injury caused by LPS (Jaeschke et al., 2002) indi-
cating that TNF-a is a critical factor in the sepsis-related liver
toxicity. The current study revealed that treatment with
PDTC reduced serum TNF-a, suggesting antiinﬂammatory
action which would partially contribute to liver protection.
PDTC bears a numbers of beneﬁcial properties including
antioxidant activity, antiinﬂammatory and immunomodula-
tory effects (Cuzzocrea et al., 2002), all of which could ac-
count for the observed protection afforded by PDTC in
this study. Moreover, PDTC can traverse the cell membrane
and has prolonged stability in solution at physiological pH;
effects that may account for its protective actions (Topping
and Jones, 1988). In addition, PDTC can inhibit the activa-
tion of the nuclear transcription factor NF-jB produced by
LPS which could result in a decrease of TNF-a synthesis
(Rahman et al., 1998). Previous studies have indicated a ma-
jor role for the NF-jB in the induction of TNF-a gene by
endotoxin (Rahman et al., 1998; Collart et al., 1990). PDTC
protected against different models of inﬂammation including
angiotensin II-induced inﬂammation (Muller et al., 2000),
carrageenan-induced pleurisy (Cuzzocrea et al., 2002), exper-
imental model of ulcerative colitis (Hagar et al., 2007) and
inﬂammatory conditions induced by ischemia/ reperfusion
to organs as kidney (Chatterjee et al., 2003), stomach (El Eter
et al., 2005) and intestine (Tian et al., 2006).
Besides TNF-a, it has been suggested that ROM as singlet
oxygen, NO, hydrogen peroxide and radicals such as superox-
ide anion and hydroxyl radicals are involved in the pathogenesis
of endotoxic shock (Morgan et al., 1988). ROM are important
cytotoxic and signaling mediators in the pathophysiology of
An insight into the possible protective effect of pyrrolidine dithiocarbamate 265inﬂammatory liver diseases (Jaeschke, 2000) and play an impor-
tant role in the onset of hepatic damage during endotoxemia or
sepsis (Spolarics, 1998). ROM can cause cellular injury via sev-
eral mechanisms including the peroxidation of membrane lipids
and the oxidative damage of proteins and DNA (Halliwel and
Gutteridge, 1990).
Lipid peroxidation is produced by the attack of ROM upon
the cell membrane resulting in membrane ﬂuidity and perme-
ability, which eventually leads to oxidative destruction of cel-
lular membranes and cell lysis (Halliwel and Gutteridge,
1990). In this study, the results clearly showed that LPS could
induce production of ROM measured indirectly by elevated
hepatic TBARS. It is possible that the damage inﬂicted by lipid
peroxidation upon lysosomal membranes in animals exposed
to LPS enhanced the leakage of hydrolytic enzymes, and thus
can severely injure the cells or tissues. Moreover, products of
lipid peroxidation are potent chemotactic factors for neutro-
phils and can modulate their reactive oxygen formation (Cur-
zio et al., 1986). They may also be involved in the generation of
chemokines (Jayatilleke and Shaw, 1998). These ﬁnding indi-
cate that lipid peroxidation products are the determining fac-
tor for the continuation of neutrophils recruitment and
aggravation of the injury (Wang et al., 1996). In this study,
PDTC protected against LPS-induced lipid peroxidation as
indicated by reduction in hepatic TBARS and thereby sup-
ported antioxidant activity of PDTC. Indeed inhibition of lipid
peroxidation improves survival rate of endotoxemic rats (Kun-
imoto et al., 1987). PDTC functions as an antioxidant due to
two structural features: direct scavenging of ROM by the
dithiocarboxy group, and chelating activity for heavy metal
ions that may catalyze formation of ROM. In addition, PDTC
protects against NF-jB-mediated pathological effects induced
by various stimuli including LPS and cytokines (Liu and Mal-
ik, 1999; Rahman et al., 1998). ROM has been reported to be a
crucial event in the activation of NF-jB (Shreck et al., 1992).
Therefore, it has been proposed that antioxidants, by quench-
ing ROM, may in turn block NF-jB activation and ﬁnally in-
hibit TNF-a production.
The cells are normally equipped with protective cell defense
mechanisms, which include SOD, catalase, and GSH (Iszard
et al., 1995). The balance between prooxidant production
and antioxidant defense is pivotal for a correct cell function,
whereas a disturbance in this balance in favour of the oxidants
represents an oxidative stress. Several reports indicate that, tis-
sue injury induced by various stimuli, including sepsis is cou-
pled with GSH depletion (Hsu et al., 2004). The present
study also demonstrated that sepsis yields in depletion of the
hepatic GSH stores. With inﬂammation, GSH level in the liver
decreases (Paradkar et al., 2004). LPS could have caused con-
sumption of GSH to protect against ROM production or it
may cause efﬂux of intracellular GSH, as suggested by others
(Jaeschke, 1992). It is well known that GSH, the main intracel-
lular nonprotein sulfhydryl, plays an important role in the
maintenance of cellular proteins and lipids in their functional
state, and provides major protection in oxidative injury by par-
ticipating in the cellular defense systems against oxidative
damage (Jefferies et al., 2003).
In addition to GSH, SOD and catalase constitute the de-
fense antioxidant system against ROM. In the current investi-
gation, LPS-induced a decline in hepatic SOD and catalase
activities. These results are in accordance with previous studies
that have been suggested that ROM production mainly super-oxide anion and hydroxyl radical, may be a major cause of
LPS-induced oxidative stress (Hsu et al., 2004). LPS may acti-
vate neutrophils to produce a number of short-lived ROM
including superoxide anion, hydrogen peroxide and hydroxyl
radical (Bautista et al., 1990; Beckman et al., 1990). PDTC
administration prevented the depletion of SOD and catalase
in hepatic tissues, thus it appears that the protective effect of
PDTC may involve the maintenance of antioxidant capacity
in protecting tissues against LPS-induced oxidant stress.
In the present study, LPS administration in rats resulted in
remarkable increase in serum nitrite level, as a measure of NO
production, which was attenuated by PDTC-pretreatment.
Under normal conditions, it is well established that NO levels
are low; however, the administration of LPS may cause the
induction of NO synthase (iNOS), resulting in the production
of large quantities of NO in many organs including the liver
(Zhang et al., 2000). In the liver, LPS-activated Kupffer cells,
endothelial cells, and hepatocytes are known to be a source of
iNOS-derived NO (Duval et al., 1996; Rockey and Chung,
1996). In addition, inﬂammatory cells such as phagocytic leu-
kocytes express iNOS when appropriately stimulated by cyto-
kines (e.g. TNF-a and IL-1b) or by LPS (Rachmilewitz et al.,
1995). Sustained production of NO after LPS challenge may
cause hepatocellular injury either directly or indirectly. NO it-
self, or through one of its metabolites, can promote oxidant
stress and thus provide an environment favouring the genera-
tion of more reactive species leading to hepatocellular injury.
NO may participate in the development of oxidant stress in
a number of ways. The loss of a single electron generates the
highly reactive nitrosyl cation (NO1) Stamler, 1984. In addi-
tion, the reaction of NO with superoxide radical generates per-
oxinitrite ONOO2 (Cuzzocrea et al., 2006). Both NO1 and
ONOO2 are potent oxidants that can react with lipids, pro-
teins, DNA, and GSH (Stamler, 1984). Generation of these
reactive species could also explain the increased lipid peroxida-
tion and the loss of GSH and the appearance of markers of
oxidant stress. In the current study, PDTC reduced serum ni-
trite level and protected against LPS-induced oxidative hepatic
injury. These results conﬁrm the role of NO in LPS-induced li-
ver injury. Inhibition of NO synthesis greatly reduced oxidant
stress in the liver after LPS administration (Zhang et al., 2000).
Although the mechanisms by which PDTC attenuated the
LPS-induced increase in serum NO cannot be delineated from
the results of this study, it is possible that PDTC might exert its
protective effect by down-regulating the expression of iNOS.
Results from studies examining the role of PDTC on different
models of inﬂammation revealed that PDTC was able to de-
crease the synthesis of NO by preventing the up-regulation
of iNOS expression (Cuzzocrea et al., 2002; El Eter et al.,
2005; Hagar et al., 2007). The molecular regulation of iNOS
expression resulting in excessive amounts of serum NO re-
leased is a complex event and requires the transcription factor,
NF-jB (Leist et al., 1995; Van den Berg et al., 2001). It has
been shown that down-regulation of NF-jB with antioxidants
resulted in decreases in the amount of NO released in the cir-
culation, a treatment effect attributed to the reduction in iNOS
expression (Hur et al., 1999). Another explanation for the
reduction in serum NO level might be due to the direct
scavenging effect of NO by the sulphydryl groups of PDTC.
Collectively, the results of the present study demonstrated that
PDTC provided protection against LPS-induced oxidative
stress and acute hepatic damage via its antioxidant and
266 H.H. Hagarantiinﬂammatory effects. PDTC may have a beneﬁcial effect in
liver injury involving oxidative stress and endotoxemia.
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